Profile picture

Doctor Jose Pedro Sousa

Porto (Portugal)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

PFO closure for the prevention of cerebrovascular events in high-risk individuals: an updated and across-the-board meta-analysis
Presentation
PFO closure for the prevention of cerebrovascular events in high-risk individuals: an updated and across-the-board meta-analysis
Read more
Bisphosphonates and atrial fibrillation risk: a final word
Presentation
Bisphosphonates and atrial fibrillation risk: a final word
Read more
Subsegmental pulmonary embolism: yet another case for being a medical conservative
Presentation
Subsegmental pulmonary embolism: yet another case for being a medical conservative
Read more
The quest for GRACE 3.0: improving our beloved risk score with machine learning
Presentation
The quest for GRACE 3.0: improving our beloved risk score with machine learning
Read more
Do alpha-adrenergic blockers really increase the risk of poor cardiovascular outcomes? An across-the-board meta-analysis
Presentation
Do alpha-adrenergic blockers really increase the risk of poor cardiovascular outcomes? An across-the-board meta-analysis
Read more
Dexrazoxane role in the prevention of anthracycline cardiotoxicity in children with acute leukemia: a meta-analysis
Presentation
Dexrazoxane role in the prevention of anthracycline cardiotoxicity in children with acute leukemia: a meta-analysis
Read more
Getting to know the middle child
Presentation
Getting to know the middle child
Read more
Selective serotonin reuptake inhibitors for debilitating vasovagal syncope: looking for copper and finding gold
Presentation
Selective serotonin reuptake inhibitors for debilitating vasovagal syncope: looking for copper and finding gold
Read more
Statins for venous thromboembolism prevention: old dog, new tricks
Presentation
Statins for venous thromboembolism prevention: old dog, new tricks
Read more
Ranolazine as you have never seen it before: an antiarrhythmic for atrial fibrillation
Presentation
Ranolazine as you have never seen it before: an antiarrhythmic for atrial fibrillation
Read more

ESC 365 is supported by

novartis Explore sponsored resources